Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Fast and Easy Money in Penny Stocks -- Ignore unavailable to you. Want to Upgrade?

To: InAndOut who wrote (621)	3/26/1999 1:06:00 AM
From: Tracy Moore	Respond to of 3517

Nice close on WPNE. Tomorrow AM should tell the tale! Since biotech aint hot these days, its not an OFFICIAL PICK, but a personal favorite SUGN at $17.87 may finally be headed for greatness. Before the NETS, 4 years ago my main investment focus was on biotechs. Last year I was dismayed that ENMD stole the biotech spotlite and ran from 12-80 on RAT ANGIOGENISIS trials and a NY Times story. SUGN is in PHASE 2 FDA HUMAN trials on Angiogenesis and is being featured on THE BIGGEST BIOTECH PR SINCE ENMD- a special 2 hour "60 Minutes", the #1 ratings star, on April 4. I bought a tidbit of SUGN today- & some of the FEMPSters bought some April Calls... On a side note, I actually met SUGN CEO Evans-Freke 2 years ago at a conference, and I have to say out of all the hundreds of CEO's I've talked to(even penny stock CEO's), he's the ONLY ONE to with the BALLS to say: "One day, I'm gonna make the shareholders FILTHY RICH!" ROFL! Well maybe next Monday after 60 minutes will be THE DAY! SUGN also has a PSORIASIS drug in FDA trials, kinda sorta just like PRXX...